The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
From machine learning to deep learning: progress in machine intelligence for rational drug discovery
Abstract
Machine intelligence, which is normally presented as artificial intelligence, refers to the intelligence exhibited by computers. In the history of rational drug discovery, various machine intelligence approaches have been applied to guide traditional experiments, which are expensive and time-consuming. Over the past several decades, machine-learning tools, such as quantitative structure-activity relationship (QSAR) modeling, were developed that can identify potential biological active molecules from millions of candidate compounds quickly and cheaply. However, when drug discovery moved into the era of 'big' data, machine learning approaches evolved into deep learning approaches, which are a more powerful and efficient way to deal with the massive amounts of data generated from modern drug discovery approaches. Here, we summarize the history of machine learning and provide insight into recently developed deep learning approaches and their applications in rational drug discovery. We suggest that this evolution of machine intelligence now provides a guide for early-stage drug design and discovery in the current big data era.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There are various tasks in the drug discovery process where machine learning can be used to streamline the tasks. This includes drug compound property and activity prediction, de novo design of drug compounds, drug–receptor interactions, and drug reaction prediction [16].”
From The rise of artificial intelligence in healthcare applications (2020) · cites this paper as [16]
In the citing paper
“QSAR modeling methods, such as linear discriminant analysis (LDA), support vector machines (SVMs), random forest (RF), and decision trees, have been used to identify prospective drug candidates and have evolved into AI-based QSAR approaches can use that to speed up QSAR analysis”
From Blockchain and Artificial Intelligence Technology in E-Health (2021) · cites this paper as Zhang 2017 & Jain 2015
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
Wu, Y., & Vapnik, V. N. (1999) · Technometrics · doi:10.2307/1271368 · Cited by 27,236
Deep learning in neural networks: an overview
Schmidhuber, J. (2015) · Neural Networks · doi:10.1016/j.neunet.2014.09.003 · Cited by 18,570
Eigenfaces vs. Fisherfaces: recognition using class specific linear projection
Belhumeur, P. N., Hespanha, J. P., & Kriegman, D. J. (1997) · IEEE Transactions on Pattern Analysis and Machine Intelligence · doi:10.1109/34.598228 · Cited by 11,798
An Introduction to Kernel and Nearest-Neighbor Nonparametric Regression
Altman, N. (1992) · The American Statistician · doi:10.1080/00031305.1992.10475879 · Cited by 5,657
Predicting the sequence specificities of DNA- and RNA-binding proteins by deep learning
Alipanahi, B., Delong, A., Weirauch, M. T., & Frey, B. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3300 · Cited by 2,873
Bioisosterism: A Rational Approach in Drug Design
Patani, G. A., & LaVoie, E. J. (1996) · Chemical Reviews · doi:10.1021/cr950066q · Cited by 1,344
Big data deep learning: Challenges and perspectives
Chen, X.-W., & Lin, X. (2014) · IEEE Access · doi:10.1109/access.2014.2325029 · Cited by 1,255
Flagged first, then by citations
1 of the 60 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Hinton, 2006, 8, 1527
- Jain, 2015, In silico de novo design of novel NNRTIs: a bio-molecular modelling approach, RSC Adv., 5, 14814, 10.1039/C4RA15478A · DOI
- Unterthiner, 2014, Deep learning as an opportunity in virtual screening, Proc. Deep Learning Workshop NIPS
Cited by
Sorted by citations
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
The rise of artificial intelligence in healthcare applications
Bohr, A., & Memarzadeh, K. (2020) · Artificial Intelligence in Healthcare · doi:10.1016/b978-0-12-818438-7.00002-2 · Cited by 1,636
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Thus, the biggest question that arises in front of pharmaceutical companies is managing the cost and speed of the process [5].”
BackgroundNatural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Thomford, N. E., Senthebane, D. A., Rowe, A., Munro, D., Seele, P. P., Maroyi, A., & Dzobo, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061578 · Cited by 1,301
Drug discovery with explainable artificial intelligence
Jiménez-Luna, J., Grisoni, F., & Schneider, G. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-020-00236-4 · Cited by 1,063
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X. Y., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,079
Next-Generation Machine Learning for Biological Networks
Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C., & Collins, J. J. (2018) · Cell · doi:10.1016/j.cell.2018.05.015 · Cited by 1,012
Schneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
ADMET modeling approaches in drug discovery
Ferreira, L. L. G., & Andricopulo, A. D. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.015 · Cited by 857
Development and evaluation of a deep learning model for protein–ligand binding affinity prediction
Stepniewska-Dziubinska, M. M., Zielenkiewicz, P., & Siedlecki, P. S. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty374 · Cited by 673
Jiang, D., Wu, Z., Hsieh, C.-Y., Chen, G., Liao, B., Wang, Z., Shen, C., Cao, D., Wu, J., & Hou, T. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-020-00479-8 · Cited by 664
Manickam, P., Mariappan, S. A., Murugesan, S. M., Hansda, S., Kaushik, A. K., Shinde, R. B., & Thipperudraswamy, S. P. (2022) · Biosensors · doi:10.3390/bios12080562 · Cited by 717
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 665
A drug-likeness toolbox facilitates ADMET study in drug discovery
Jia, C., Li, J., Hao, G., & Yang, G. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.10.014 · Cited by 570
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Big data and artificial intelligence modeling for drug discovery
Zhu, H. (2020) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010919-023324 · Cited by 455
Self-citationResearch and application of machine learning for additive manufacturing
Qin, J., Hu, F., Liu, Y., Witherell, P., Wang, C. C. L., Rosen, D. W., Simpson, T. W., Lu, Y., & Tang, Q. (2022) · Additive Manufacturing · doi:10.1016/j.addma.2022.102691 · Cited by 391
Reinforced Adversarial Neural Computer for de Novo Molecular Design
Lane, E., Asadulaev, A., Ivanenkov, Y. A., Aladinskiy, V., Sánchez-Lengeling, B., Aspuru‐Guzik, A., & Zhavoronkov, A. A. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.7b00690 · Cited by 388
Artificial Intelligence in Drug Design
Heßler, G., & Baringhaus, K. H. (2018) · Molecules · doi:10.3390/molecules23102520 · Cited by 396
Autonomous Discovery in the Chemical Sciences Part I: Progress
Coley, C. W., Eyke, N. S., & Jensen, K. F. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201909987 · Cited by 371
Potential of quantum computing for drug discovery
Cao, Y., Romero, J., & Aspuru-Guzik, A. (2018) · IBM Journal of Research and Development · doi:10.1147/jrd.2018.2888987 · Cited by 357
Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis
Niazi, S. K., & Mariam, Z. (2023) · Pharmaceuticals · doi:10.3390/ph17010022 · Cited by 371
Park, S.-O., Jeong, H., Park, J., Bae, J., & Choi, S. (2022) · Nature Communications · doi:10.1038/s41467-022-30539-6 · Cited by 331
“All experiments are conducted in a 20 × 20 gradual TiO x memristor cross-bar array, where a single cell size is 5 × 5 µm 2 .”
MethodTackling climate change with machine learning
Rolnick, D., Donti, P. L., Kaack, L. H., Kochanski, K., Lacoste, A., Sankaran, K., Ross, A. S., Milojevic-Dupont, N., Jaques, N., Waldman-Brown, A., et al. (2023) · ACM Computing Surveys · doi:10.1145/3485128 · Cited by 336
Guedes, I. A., Pereira, F. S. S., & Dardenne, L. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01089 · Cited by 331
The significance of artificial intelligence in drug delivery system design
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.001 · Cited by 326
Integrated phenology and climate in rice yields prediction using machine learning methods
Guo, Y., Fu, Y. H., Hao, F., Zhang, X., Wu, W., Jin, X., Bryant, C. R., & Senthilnath, J. (2020) · Ecological Indicators · doi:10.1016/j.ecolind.2020.106935 · Cited by 315
Blockchain and Artificial Intelligence Technology in E-Health
Tagde, P., Tagde, S., Bhattacharya, T., Tagde, P., Chopra, H., Akter, R., Kaushik, D., & Rahman, M. H. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16223-0 · Cited by 281
Artificial Intelligence in Pharmaceutical and Healthcare Research
Bhattamisra, S. K., Banerjee, P., Gupta, P., Mayuren, J., Patra, S., & Candasamy, M. (2023) · Big Data and Cognitive Computing · doi:10.3390/bdcc7010010 · Cited by 298
CADD, AI and ML in drug discovery: A comprehensive review
Vemula, D., Jayasurya, P., Sushmitha, V., Kumar, Y. N., & Bhandari, V. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106324 · Cited by 275
From machine learning to deep learning: Advances in scoring functions for protein–ligand docking
Shen, C., Ding, J., Wang, Z., Cao, D., Ding, X., & Hou, T. (2019) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1429 · Cited by 255
Advancing computer-aided drug discovery (CADD) by big data and data-driven machine learning modeling
Zhao, L., Ciallella, H. L., Aleksunes, L. M., & Zhu, H. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.005 · Cited by 244
Self-citationMachine learning applications in drug development
Réda, C., Kaufmann, E., & Delahaye‐Duriez, A. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.006 · Cited by 235
Neural network and deep-learning algorithms used in QSAR studies: merits and drawbacks
Ghasemi, F., Mehridehnavi, A., Pérez-Garrido, A., & Pérez‐Sánchez, H. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.06.016 · Cited by 232
The prospects of quantum computing in computational molecular biology
Outeiral, C., Strahm, M., Shi, J., Morris, G. M., Benjamin, S. C., & Deane, C. M. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1481 · Cited by 232
Game theory interpretation of digital soil mapping convolutional neural networks
Padarian, J., McBratney, A. B., & Minasny, B. (2020) · SOIL · doi:10.5194/soil-6-389-2020 · Cited by 184
Deep learning models in genomics; are we there yet?
Koumakis, L. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.017 · Cited by 194
Deep learning tools for advancing drug discovery and development
Nag, S., Baidya, A. T. K., Mandal, A., Mathew, A. T., Das, B., Devi, B., & Kumar, R. (2022) · 3 Biotech · doi:10.1007/s13205-022-03165-8 · Cited by 185
Sevakula, R. K., Au-Yeung, W.-T. M., Singh, J. P., Heist, E. K., Isselbacher, E. M., & Armoundas, A. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.013924 · Cited by 182
Machine‐learning scoring functions for structure‐based virtual screening
Li, H., Sze, K., Lü, G., & Ballester, P. J. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1478 · Cited by 171
Aminpour, M., Montemagno, C. D., & Tuszyński, J. A. (2019) · Molecules · doi:10.3390/molecules24091693 · Cited by 175
Bai, Q., Liu, S., Tian, Y., Xu, T., Banegas‐Luna, A. J., Pérez‐Sánchez, H., Huang, J., Liu, H., & Yao, X. (2022) · WIREs Computational Molecular Science · doi:10.1002/wcms.1581 · Cited by 156
Toxicity prediction based on artificial intelligence: A multidisciplinary overview
Pérez Santín, E., Rodríguez Solana, R., González García, M., García Suárez, M. D. M., Blanco Díaz, G. D., Cima Cabal, M. D., Moreno Rojas, J. M., & López Sánchez, J. I. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1516 · Cited by 153
Application of Computational Biology and Artificial Intelligence in Drug Design
Zhang, Y., Luo, M., Wu, P., Wu, S., Lee, T.-Y., & Bai, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113568 · Cited by 167
Yang, S., & Kar, S. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100011 · Cited by 162
Artificial intelligence in cancer diagnosis and therapy: Current status and future perspective
Sufyan, M., Shokat, Z., & Ashfaq, U. A. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107356 · Cited by 170
Mrksich, K., Padilla, M. S., & Mitchell, M. J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115446 · Cited by 162
Computational Drug Design Methods—Current and Future Perspectives
Prieto-Martínez, F. D., López‐López, E., Juárez‐Mercado, K. E., & Medina‐Franco, J. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00002-x · Cited by 156
Machine‐learning scoring functions for structure‐based drug lead optimization
Li, H., Sze, K., Lü, G., & Ballester, P. J. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1465 · Cited by 150
Morphological, Physiological and Molecular Markers for Salt-Stressed Plants
Soltabayeva, A., Ongaltay, A., Omondi, J. O., & Srivastava, S. (2021) · Plants · doi:10.3390/plants10020243 · Cited by 157
Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery
Tripathi, M. K., Nath, A., Singh, T. P., Ethayathulla, A. S., & Kaur, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10256-w · Cited by 151
Advances in Artificial Intelligence (AI)-assisted approaches in drug screening
Singh, S., Gupta, H., Sharma, P., & Sahi, S. (2023) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2023.100039 · Cited by 153
Niazi, S. K. (2023) · Drug Design Development and Therapy · doi:10.2147/dddt.s424991 · Cited by 152
Recent applications of machine learning in medicinal chemistry
Panteleev, J., Gao, H., & Jia, L. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.06.046 · Cited by 131
A Distinctive Explainable Machine Learning Framework for Detection of Polycystic Ovary Syndrome
Khanna, V. V., Chadaga, K., Sampathila, N., Prabhu, S., Bhandage, V. A., & Hegde, G. K. (2023) · Applied System Innovation · doi:10.3390/asi6020032 · Cited by 145
In silico approaches and tools for the prediction of drug metabolism and fate: A review
Kazmi, S. R., Ren, J., Yu, M., Jung, C., & Na, D. (2019) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2019.01.008 · Cited by 128
Virtual screening web servers: designing chemical probes and drug candidates in the cyberspace
Singh, N., Chaput, L., & Villoutreix, B. O. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa034 · Cited by 125
CIoT-Net: a scalable cognitive IoT based smart city network architecture
Park, J.-H., Salim, M. M., Jo, J. H., Sicato, J. C. S., Rathore, S., & Park, J. H. (2019) · Human-centric Computing and Information Sciences · doi:10.1186/s13673-019-0190-9 · Cited by 121
Drug–Membrane Permeability across Chemical Space
Menichetti, R., Kanekal, K. H., & Bereau, T. (2019) · ACS Central Science · doi:10.1021/acscentsci.8b00718 · Cited by 124
A review on compound-protein interaction prediction methods: Data, format, representation and model
Lim, S., Lu, Y., Cho, C. Y., Sung, I., Kim, J.-W., Kim, Y., Park, S., & Kim, S. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.03.004 · Cited by 120
Transfer and Multi-task Learning in QSAR Modeling: Advances and Challenges
Simões, R. D. S., Maltarollo, V. G., Oliveira, P. R., & Honório, K. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00074 · Cited by 120
Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery
Lane, T. R., Russo, D. P., Zorn, K. M., Clark, A. M., Korotcov, A. V., Tkachenko, V., Reynolds, R. C., Perryman, A. L., Freundlich, J. S., & Ekins, S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00083 · Cited by 119
Revolutionizing Drug Discovery: A Comprehensive Review of AI Applications
Dhudum, R., Ganeshpurkar, A., & Pawar, A. (2024) · Drugs and Drug Candidates · doi:10.3390/ddc3010009 · Cited by 131
Automated Experimentation Powers Data Science in Chemistry
Shi, Y. J., Prieto, P. L., Zepel, T., Grunert, S., & Hein, J. E. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00736 · Cited by 122
Madani, M., Behzadi, M. M., & Nabavi, S. (2022) · Cancers · doi:10.3390/cancers14215334 · Cited by 128
Machine Learning and Big Data Provide Crucial Insight for Future Biomaterials Discovery and Research
Kerner, J., Dogan, A. B., & von Recum, H. A. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.05.053 · Cited by 106
Applications of deep learning for the analysis of medical data
Jang, H., & Cho, K. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01162-9 · Cited by 108
Nayarisseri, A., Khandelwal, R., Tanwar, P., Madhavi, M., Sharma, D., Thakur, G., Speck‐Planche, A., & Singh, S. K. (2021) · Current Drug Targets · doi:10.2174/1389450122999210104205732 · Cited by 105
Srinivasan, M., Venugopal, A., Venkatesan, L., & Kumar, R. (2024) · JMIR Nursing · doi:10.2196/52105 · Cited by 96
Artificial Intelligence in Materials Modeling and Design
Huang, J., Liew, J. X., Ademiloye, A. S., & Liew, K. M. (2020) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-020-09506-1 · Cited by 99
An Analysis of QSAR Research Based on Machine Learning Concepts
Keyvanpour, M. R., & Shirzad, M. B. (2020) · Current Drug Discovery Technologies · doi:10.2174/1570163817666200316104404 · Cited by 96
Revealing Drug-Target Interactions with Computational Models and Algorithms
Zhou, L., Li, Z., Yang, J., Tian, G., Liu, F., Wen, H., Li, P., Chen, M., Xiang, J., & Peng, L. (2019) · Molecules · doi:10.3390/molecules24091714 · Cited by 95
Harnessing machine learning for development of microbiome therapeutics
McCoubrey, L. E., Elbadawi, M., Orlu, M., Gaisford, S., & Basit, A. W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1872323 · Cited by 97
Ali, R. S. A. E., Meng, J., Khan, M. E. I., & Jiang, X. (2024) · Artificial Intelligence Chemistry · doi:10.1016/j.aichem.2024.100049 · Cited by 103
Improved Classification of Blood-Brain-Barrier Drugs Using Deep Learning
Miao, R., Xia, L.-Y., Chen, H.-H., Huang, H.-H., & Liang, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-44773-4 · Cited by 91
Gowd, A. K., Agarwalla, A., Amin, N. H., Romeo, A. A., Nicholson, G. P., Verma, N. N., & Liu, J. N. (2019) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2019.05.017 · Cited by 91
Khanam, M. M., Uddin, M. K., & Kazi, J. U. (2025) · Frontiers in Environmental Science · doi:10.3389/fenvs.2025.1573579 · Cited by 101
Recurrent neural networks (RNNs) learn the constitutive law of viscoelasticity
Chen, G. (2021) · Computational Mechanics · doi:10.1007/s00466-021-01981-y · Cited by 97
Influence of artificial intelligence in modern pharmaceutical formulation and drug development
Ali, K. A., Mohin, S., Mondal, P., Goswami, S., Ghosh, S., & Choudhuri, S. (2024) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-024-00625-1 · Cited by 106
Kausik, A. K., Rashid, A. B., Baki, R. F., & Maktum, M. M. J. (2025) · Array · doi:10.1016/j.array.2025.100393 · Cited by 112
Advances and challenges in deep generative models for de novo molecule generation
Xue, D., Gong, Y., Yang, Z., Chuai, G., Qu, S., Shen, A., Yu, J., & Liu, Q. (2018) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1395 · Cited by 85
DeepScreening: a deep learning-based screening web server for accelerating drug discovery
Liu, Z., Du, J., Fang, J., Yin, Y., Xu, G., & Xie, L. (2019) · Database · doi:10.1093/database/baz104 · Cited by 89
Use of big data in drug development for precision medicine: an update
Qian, T., Zhu, S., & Hoshida, Y. (2019) · Expert Review of Precision Medicine and Drug Development · doi:10.1080/23808993.2019.1617632 · Cited by 87
Artificial intelligence facilitates drug design in the big data era
Wang, L., Ding, J., Pan, L., Cao, D., Jiang, H., & Ding, X. (2019) · Chemometrics and Intelligent Laboratory Systems · doi:10.1016/j.chemolab.2019.103850 · Cited by 80
Accelerating 3D printing of pharmaceutical products using machine learning
Ong, J. J., Muñiz, B., Gaisford, S., Cabalar, P., Basit, A. W., Pérez, G., & Goyanes, Á. (2022) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2022.100120 · Cited by 79
Exploring Tunable Hyperparameters for Deep Neural Networks with Industrial ADME Data Sets
Zhou, Y., Cahya, S., Combs, S. A., Nicolaou, C. A., Wang, J., Desai, P. V., & Shen, J. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00671 · Cited by 82
Lin, F., Cui, E., Yi, L., & Luo, L. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-01992-7 · Cited by 79
Machine learning on adverse drug reactions for pharmacovigilance
Lee, C. Y., & Chen, Y. P. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.003 · Cited by 80
Few-shot classification of ultrasound breast cancer images using meta-learning algorithms
Işık, G., & Paçal, İ. (2024) · Neural Computing and Applications · doi:10.1007/s00521-024-09767-y · Cited by 75
A Deep Learning-Based Chemical System for QSAR Prediction
Hu, S., Chen, P., Gu, P., & Wang, B. (2020) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2020.2977009 · Cited by 74
Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches
Das, A. P., & Agarwal, S. M. (2023) · Molecular Diversity · doi:10.1007/s11030-022-10590-7 · Cited by 79
Compound–protein interaction prediction by deep learning: Databases, descriptors and models
Du, B.-X., Qin, Y., Jiang, Y., Xu, Y., Yiu, S., Yu, H., & Shi, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.023 · Cited by 76
The Potential Applications of Artificial Intelligence in Drug Discovery and Development
Farghali, H., Kutinová Canová, N., & Arora, M. (2021) · Physiological Research · doi:10.33549/physiolres.934765 · Cited by 72
Kim, H., Lee, J., Ahn, S., & Lee, J. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-90259-7 · Cited by 75
Tripathi, N., Goshisht, M. K., Sahu, S. K., & Arora, C. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10237-z · Cited by 75
Yang, X., Zhang, N., & Schrader, P. T. (2022) · Machine Learning with Applications · doi:10.1016/j.mlwa.2022.100290 · Cited by 75
Ajith, S., Vijayakumar, S., & Elakkiya, N. (2025) · Discover Food · doi:10.1007/s44187-025-00338-1 · Cited by 91
Computational advances in combating colloidal aggregation in drug discovery
Reker, D., Bernardes, G. J. L., & Rodrigues, T. (2019) · Nature Chemistry · doi:10.1038/s41557-019-0234-9 · Cited by 71
Artificial Intelligence in Vaccine and Drug Design
Thomas, S., Abraham, A., Baldwin, J., Piplani, S., & Petrovsky, N. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1884-4_6 · Cited by 74
Application of artificial intelligence in drug design: A review
Singh, S., Kaur, N., & Gehlot, A. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108810 · Cited by 76
Metadata
- Authors
- Zhang, L., Tan, J., Han, D., & Zhu, H.
- Affiliations
- Beijing University of Technology (CN)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Tan, Jianjun
- Zhu, Hao
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 22
- Issue
- 11
- Pages
- 1680-1685
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2753588101
- Cited by
- 760
- References
- 60
- Citations by year
- 2026: 42 · 2025: 90 · 2024: 105 · 2023: 134 · 2022: 112 · 2021: 96 · 2020: 79 · 2019: 61 · 2018: 39 · 2017: 2
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Chinese Natural Science Foundation Project (21173014)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- rational drug discovery, deep learning, machine learning, QSAR, big data, history of machine learning, computer-aided drug design
- MeSH terms
- Machine Learning, Artificial Intelligence, Humans, Models, Theoretical, Drug Design, Quantitative Structure-Activity Relationship, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review